These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 28383438)

  • 21. Percutaneous Closure of Patent Foramen Ovale in Patients With Migraine: The PREMIUM Trial.
    Tobis JM; Charles A; Silberstein SD; Sorensen S; Maini B; Horwitz PA; Gurley JC
    J Am Coll Cardiol; 2017 Dec; 70(22):2766-2774. PubMed ID: 29191325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AMPLATZER versus Figulla occluder for transcatheter patent foramen ovale closure.
    Trabattoni D; Gaspardone A; Sgueglia GA; Fabbiocchi F; Gioffrè G; Montorsi P; Calligaris G; Iamele M; De Santis A; Bartorelli AL
    EuroIntervention; 2017 Apr; 12(17):2092-2099. PubMed ID: 27993750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-Term Outcome After Percutaneous Closure of Patent Foramen Ovale for Cryptogenic Ischemic Events.
    Seeger J; Uber A; Wöhrle J
    J Invasive Cardiol; 2019 Aug; 31(8):E242-E248. PubMed ID: 31368895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Post-Market Clinical Follow-Up With the Patent Foramen Ovale Closure Device IrisFIT (Lifetech) in Patients With Stroke, Transient Ischemic Attack, or Other Thromboembolic Events.
    Sievert K; Yu J; Bertog S; Hornung M; von Bardeleben RS; Gafoor S; Reinartz M; Matic P; Hofmann I; Grunwald I; Schnelle N; Sievert H
    Cardiovasc Revasc Med; 2021 Sep; 30():72-75. PubMed ID: 33097460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amplatzer patent foramen ovale occluder: safety and efficacy.
    Madhkour R; Wahl A; Praz F; Meier B
    Expert Rev Med Devices; 2019 Mar; 16(3):173-182. PubMed ID: 30741039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Residual shunt after percutaneous closure of patent foramen ovale with AMPLATZER occluder devices - influence of anatomic features: a transcranial Doppler and intracardiac echocardiography study.
    Marchese N; Pacilli MA; Inchingolo V; Fanelli R; Loperfido F; Vigna C
    EuroIntervention; 2013 Jul; 9(3):382-8. PubMed ID: 23872652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multidisciplinary assessment of PFO with substantial right-to-left shunting and medium-term follow-up after PFO device closure: A single-center experience.
    He L; Cheng GS; Du YJ; Zhang YS
    J Interv Cardiol; 2017 Aug; 30(4):362-367. PubMed ID: 28568903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficiency of transcatheter patent foramen ovale closure in children after paradoxical embolism events.
    Wawrzyńczyk M; Gałeczka M; Karwot B; Knop M; Białkowski J
    Kardiol Pol; 2016; 74(4):385-9. PubMed ID: 26412471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Late results after percutaneous closure of patent foramen ovale for secondary prevention of paradoxical embolism using the amplatzer PFO occluder without intraprocedural echocardiography: effect of device size.
    Wahl A; Tai T; Praz F; Schwerzmann M; Seiler C; Nedeltchev K; Windecker S; Mattle HP; Meier B
    JACC Cardiovasc Interv; 2009 Feb; 2(2):116-23. PubMed ID: 19463412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is routine ultrasound guidance really necessary for closure of patent foramen ovale using the Amplatzer PFO occluder?
    Fateh-Moghadam S; Steeg M; Dietz R; Bocksch W
    Catheter Cardiovasc Interv; 2009 Feb; 73(3):361-6. PubMed ID: 19133676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transthoracic echocardiography guidance during percutaneous closure of patent foramen ovale.
    Oto A; Aytemir K; Ozkutlu S; Kaya EB; Yorgun H; Canpolat U; Ateş AH; Ozkutlu H
    Echocardiography; 2011 Nov; 28(10):1074-80. PubMed ID: 21967656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of residual shunt rates in five devices used to treat patent foramen ovale.
    Matsumura K; Gevorgyan R; Mangels D; Masoomi R; Mojadidi MK; Tobis J
    Catheter Cardiovasc Interv; 2014 Sep; 84(3):455-63. PubMed ID: 24550064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intermediate and long-term results of transcatheter closure of patent foramen ovale using the amplatzer patent foramen ovale occluder: one case of pulmonary embolism irrespective of patent foramen ovale closure.
    Yoon JH; Kim JS; Lee DH; Shim EJ; Lee SY; Min KS; Cho DJ; Lee HR
    Korean Circ J; 2011 Jul; 41(7):356-62. PubMed ID: 21860636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Propensity-Score Matched Comparison of the Cera PFO Occluder With the Amplatzer PFO Occluder for Percutaneous Closure of Patent Foramen Ovale Without Echocardiographic Guidance.
    Ulmi M; Praz F; Siontis GCM; Wahl A; Windecker S; Mattle HP; Meier B
    J Invasive Cardiol; 2017 Aug; 29(8):280-284. PubMed ID: 28570259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical evaluation of a novel occluder device (Occlutech) for percutaneous transcatheter closure of patent foramen ovale (PFO).
    Krizanic F; Sievert H; Pfeiffer D; Konorza T; Ferrari M; Figulla HR
    Clin Res Cardiol; 2008 Dec; 97(12):872-7. PubMed ID: 18696022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patent foramen ovale closure in the management of cryptogenic stroke: a review of current literature and guideline statements.
    Elzanaty AM; Patel N; Sabbagh E; Eltahawy EA
    Curr Med Res Opin; 2021 Mar; 37(3):377-384. PubMed ID: 33460329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcatheter closure of patent foramen ovale associated with atrial septal aneurysm with Amplatzer Cribriform septal occluder.
    Musto C; Cifarelli A; Pandolfi C; De Felice F; Fiorilli R; Caferri G; Violini R
    J Invasive Cardiol; 2009 Jun; 21(6):290-3. PubMed ID: 19494408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardi-O-Fix duct occluder versus Amplatzer duct occluder for closure of patent ductus arteriosus.
    Celebi A; Demir IH; Saritaş T; Dedeoğlu R; Yucel IK; Demir F; Erdem A
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):961-7. PubMed ID: 23592558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Residual Shunt after Patent Foramen Ovale Device Closure in Patients With Cryptogenic Stroke: Serial Bubble Contrast Transesophageal Echocardiography Data.
    Moon J; Kim M; Oh PC; Shin DH; Park HM; Jo YY; Lee JS; Kang WC
    J Stroke Cerebrovasc Dis; 2019 Feb; 28(2):347-353. PubMed ID: 30396838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Figulla PFO occluder versus Amplatzer PFO occluder for percutaneous closure of patent foramen ovale.
    Saguner AM; Wahl A; Praz F; de Marchi SF; Mattle HP; Cook S; Windecker S; Meier B
    Catheter Cardiovasc Interv; 2011 Apr; 77(5):709-14. PubMed ID: 20931665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.